Loading…
Back to Compound Explorer
Crofelemer (SP-303)
Clinical trialMechanism of Action
Inhibits CFTR and CaCC chloride channels in intestinal epithelium, reducing chloride and water secretion into the gut lumen
Research Notes
Dragon's BloodSouth American
Crofelemer was developed from dragon's blood and approved by the FDA as Mytesi for HIV-associated non-infectious diarrhoea. It acts locally in the gut without systemic absorption.
Found In 1 Herb
3D Molecular Structure
Oligomeric proanthocyanidin
Drag to rotate · Click atoms to explore
Crofelemer (SP-303)
Oligomeric proanthocyanidinBioactive phytochemical with therapeutic properties
Representative pattern: C₄H₂NO
Atoms
Carbon
Oxygen
Nitrogen
Hydrogen
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.